CBIO

Catalyst Biosciences Inc.

This asset is no longer available for investment.

View all assets

Price

$19.41

return (12m)

55.40%

p/e

-7.21

p/bv

7.79

DIVIDEND YIELD

0.00%

CBIO price

Catalyst Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CBIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.85%

3 months

6.71%

1 year

55.40%

2 years

0.00%

5 years

1,078.58%

10 years

4,670.21%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CBIO

Valuation

P/E

-7.21

Sector -3.82

Industry -3.82

P/BV

7.79

Sector 2.08

Industry 2.08

P/Revenue (PSR)

1,224.30

Sector 2.04

Industry 2.04

EV/EBITDA

-44.43

Sector -226.01

Industry -226.01

EV/EBIT

-44.31

Sector -49.26

Industry -49.26

P/EBITDA

-7.81

Sector -21.23

Industry -21.23

P/EBIT

-7.80

Sector -31.44

Industry -31.44

P/Total Assets

6.96

Sector 1.22

Industry 1.22

P/Net Current Assets

7.98

Sector -10.53

Industry -10.53

P/Working Capital

7.93

Sector -172.76

Industry -172.76

EPS

-2.71

Sector -1.85

Industry -1.85

BVPS

2.51

Sector 2.00

Industry 2.00

Efficiency

Gross Margin

100.00%

Sector 40.67%

Industry 40.67%

EBITDA Margin

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

-100.00%

Sector -35.88%

Industry -35.88%

Net Profit Margins

-100.00%

Sector -36.71%

Industry -36.71%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-108.03%

Sector -58.37%

Industry -58.37%

ROA

-96.50%

Sector -61.30%

Industry -61.30%

ROIC

-711.05%

Sector -2,355.96%

Industry -2,355.96%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

9.66

Sector 2.88

Industry 2.88

Net Debt / EBITDA

6.93

Sector -14,081,727.47

Industry -14,081,727.47

Net Debt / EBIT

6.91

Sector -8.03

Industry -8.03

Net Debt / Equity

-1.05

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.89

Sector 0.45

Industry 0.45

Liabilities/Assets

0.11

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals CBIO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CBIO Catalyst Biosciences Inc.	$19.41	55.40%	0.00%	-7.21	7.79	-108.03%	-100.00%
JNJ Johnson & Johnson	$265.58	52.53%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.72	24.31%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$257.12	21.52%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.07	-17.59%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$143.93	80.59%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$160.17	2.40%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.64	44.28%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$72.97	-49.82%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$377.35	40.29%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$781.49	40.10%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$107.20	39.40%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$881.51	24.54%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$515.44	30.65%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$234.57	56.04%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$984.39	30.14%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$41.52	28.19%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CBIO Historical Dividends

current DY: 0.00%

5-year average DY: 26,367,120,896.98%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	1.60000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	01/03/2023	01/12/2023	24.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	286.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	09/02/2022	09/20/2022	143.00000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.92000000
Dividends	08/12/2015	08/19/2015	56.92000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.92000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.90000000
Dividends	08/12/2015	08/19/2015	56.92000000
Dividends	08/12/2015	08/19/2015	56.90000000

ABOUT Catalyst Biosciences

Catalyst Biosciences Inc.

Average Investor10 user rating

4.0 (3 people)

United States

29 years

Founded: 1997

2006

Time since IPO - 20 years

56

Employees

Catalyst Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.27 billion, with shareholders equity totaling $163.26 million.

The company employs approximately 56 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Catalyst Biosciences Inc. reported $1.04 million in revenue, generating net income of $-176.36 million.

Key financial metrics include a P/E ratio of -7.21, a price-to-book (P/B) ratio of 7.79, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CBIO.

Market cap

$1.27 billion

Net worth

$163.26 million

$163,255,000.00

Assets

$182.76 million

$182,758,000.00

Total Shares Outstanding

65.00 million

65,000,000

Average Daily Trading Volume

$313.02 Thousand

$313,020.00

Sector

Health Care

Industry

Biotechnology

CBIO

CBIO revenue and profits

Financial Results CBIO

DRAG THE FRAME TO SEE MORE DATA

CBIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$881.51 24,54% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$234.57 56,04% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$265.58 52,53% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$257.12 21,52% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$143.93 80,59% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$160.17 4,38% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.72 24,31% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$881.51 24,54% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$234.57 56,04% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$265.58 52,53% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$257.12 21,52% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$143.93 80,59% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$160.17 4,38% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.72 24,31% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of Catalyst Biosciences (CBIO) today?

A cotação de Catalyst Biosciences (CBIO) hoje está em US$ 19.41, com uma variação de 55.4% em relação ao último ano. A cotação de Catalyst Biosciences (CBIO) iniciou o ano negociando na casa dos US$ 11.86 e hoje está em US$ 19.41. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Catalyst Biosciences (CBIO) e dados de ações do Ibovespa e mercados internacionais.

Quando Catalyst Biosciences (CBIO) paga dividendos?

Catalyst Biosciences (CBIO) não distribuiu dividendos no último ano.

Is Catalyst Biosciences (CBIO) a good investment?

Atualmente, Catalyst Biosciences (CBIO) está cotada a US$ 19.41, com um P/L de -7.21, representando um desvio de -2,625% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 55.4 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 55.40%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Catalyst Biosciences (CBIO) stock?

Investir em ações de Catalyst Biosciences (CBIO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Catalyst Biosciences (CBIO) yield today?

A rentabilidade de Catalyst Biosciences (CBIO) foi de 9.85% no último mês, 55.40% no último ano e 1,078.58% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Catalyst Biosciences (CBIO) hoje, o investimento total seria de US$ 1,941.00, com base na cotação atual de US$ 19.41.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 3,016.31
Em 5 anos: US$ 22,876.24
Em 10 anos: US$ 92,589.78

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CBIO

Catalyst Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CBIO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CBIO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 26,367,120,896.98%

type

Ex - Dividend Date

payment date

value

ABOUT Catalyst Biosciences

Catalyst Biosciences Inc.

United States

29 years

2006

56

Financial Results CBIO

CBIO cash flow

Asset, Revenue and Profit Growth - CBIO

CBIO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions